Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
about
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaThe genetics and screening of familial hypercholesterolaemiaFamilial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceCriteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab PopulationMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismThe panorama of familial hypercholesterolemia in Latin America: a systematic review.Novel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients.Procedure to protect confidentiality of familial data in community genetics and genomic research.Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryUS physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.Rapid detection of 3500Q and 3531 mutations and MspI polymorphism in exon 26 at the apolipoprotein B gene.Genetic Architecture of Familial Hypercholesterolaemia.Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemiaFamilial hypercholesterolemia: A reviewTargeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represGenome-wide linkage scan of a pedigree with familial hypercholesterolemia suggests susceptibility loci on chromosomes 3q25-26 and 21q22.Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Dementia Improvement after Plasma Exchange for Familial Hypercholesterolemia.The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia.Familial hypercholesterolemia: current treatment and advances in management.Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.Familial hypercholesterolemia: the lipids or the genes?The genetics of familial hypercholesterolemia and emerging therapiesWould raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?Detection of subclinical atherosclerosis by electron beam tomography in females with heterozygous familial hypercholesterolaemia.Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing.Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and ManagementA model of care for familial hypercholesterolaemia: key role for clinical biochemistry.New Approaches in Detection and Treatment of Familial HypercholesterolemiaMipomersen and other therapies for the treatment of severe familial hypercholesterolemia.Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia.Carotid intima-media thickness in young patients with familial hypercholesterolaemiaThe Draupadi of dyslipidemia: Familial hypercholesterolemiaThe genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
P2860
Q24528552-5825A5B0-6D86-4F20-94DC-C0B4382F4F8DQ26753081-FEB557A2-5FD5-4F0B-982E-11DCE91ACC85Q26828401-D7EF9961-0135-4419-851A-4DBB4D7599A3Q27025178-9C5FCDCF-A6C9-41D4-8225-AC487E619A73Q28363810-6E0A06B4-1262-403A-9EFE-855D83EF103AQ30244116-E60188B2-2E51-4927-870B-44F5AB6E8AD6Q30412645-3577CE53-50C6-4308-B21D-373E42BF66DAQ30578109-E1E60FB2-BA1C-4070-B8FB-214616F77B52Q31063192-1E558DE7-61FF-4757-B6E6-3C78798D9B31Q31133478-5EB351AD-46EB-44AC-8E0C-712DAB6423C0Q31913438-E32C266E-4300-4502-947D-2F5A1DEF336EQ33559233-092E399A-7F4F-4013-A780-FCC12BA6D877Q33728343-8DEB02CD-1CF2-4284-8B18-3CAF4ADE24FFQ33803782-3F34DC18-241E-4360-949F-8383982C71B6Q33851411-B8ED8C3C-F014-486F-97C4-BA6D8F25B67EQ34046881-80E0BA32-74C2-4AA0-95F3-A6306014C8A7Q34055467-97521C85-DA09-4F19-B201-90C1B42CC428Q34284716-CA326C66-476B-46F2-B257-0487431BF7A7Q34387744-670611F6-66DD-49E9-B0B6-1B0CF6D8F214Q34499298-82D20F07-71A7-4D11-BA04-54FAF8FA5643Q34541236-302239FB-7762-408B-A4FD-B93E87877901Q34726677-E22526CA-A984-4625-9458-2485C0F5D431Q34769059-E51F02A8-A670-4D86-9CC9-C139B155D5A2Q34901608-10B4F054-CD1F-4D14-B06D-7183AC936C40Q35014525-ADFFA4A6-1034-4928-812F-756B634B4468Q35043485-BC2477C3-08B1-450D-987E-B205570B6CC2Q35217153-26F0B1D7-40EF-49A4-A329-C919BA1415B8Q35581955-0EE2253C-CA4E-4AC0-AB11-62CC0A5F2FE4Q35592865-68711922-A2A0-4E21-A44D-2F1FAB17F035Q35756629-CA8FFFDA-3A00-4D4B-8FD3-D2C7CEA9E849Q35771729-E1EDFC6F-A6A9-4FC4-ACB7-A71007CCEBB0Q36177473-D80F542B-8B77-4A4C-BEA6-3D87BD1967A3Q36443821-86113653-CD74-43DA-8FC5-819BC3805D95Q36617485-62F6AD64-6FCD-40AF-8E84-1FBEB9D8030CQ36634114-491F9EF4-7FEF-4C56-8EA7-68794BDA8A46Q36787967-68485BD5-41D9-407C-A1D2-497E94D6405CQ36836837-F161D0A6-B420-4048-9BE2-488CF77BC36BQ36867393-919EF9CE-FC70-408C-A4E9-A4C2C119566EQ36925157-1058127C-E920-4722-A003-EFF3DA819079Q36966952-571E6305-3D29-404F-A294-174DACC968F0
P2860
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
description
article
@en
im Juli 1993 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1993
@uk
name
Diagnosing heterozygous famili ...... alidated by molecular genetics
@en
Diagnosing heterozygous famili ...... alidated by molecular genetics
@nl
type
label
Diagnosing heterozygous famili ...... alidated by molecular genetics
@en
Diagnosing heterozygous famili ...... alidated by molecular genetics
@nl
prefLabel
Diagnosing heterozygous famili ...... alidated by molecular genetics
@en
Diagnosing heterozygous famili ...... alidated by molecular genetics
@nl
P2093
P1476
Diagnosing heterozygous famili ...... alidated by molecular genetics
@en
P2093
Erwin H. Ludwig
M.Catherine Schumacher
Mark F. Leppert
Paul N. Hopkins
Roger R. Williams
P304
P356
10.1016/0002-9149(93)90155-6
P407
P577
1993-07-01T00:00:00Z